European drug regulators are reviewing the risk of thoughts of suicide and self-harm in people taking Ozempic and another weight-loss drug after getting three reports
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
https://www.wsj.com/articles/europe-is-probing-whether-ozempic-use-raises-risk-of-suicidal-thoughts-8c82533eShareDiabetes drugs could become an effective way to treat behavioral issues and addiction. WSJ’s Daniela Hernandez breaks down the science on how they work and how they could change psychiatry forever. Photo illustration: Elizabeth SmelovOzempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to theDow Jones & Company, Inc.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
EU probes Ozempic, weight-loss drug Saxenda after reports of suicidal thoughtsThe European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.
Les mer »
EU Investigates Ozempic Maker After Reports Of Suicidal ThoughtsThe Danish pharma giant finds itself under scrutiny once again- this time, from European regulators.
Les mer »
Popular weight loss drug gets new warningWegovy and Ozempic are brand names for a drug called semaglutide.
Les mer »
Paul Wesley Revealed Whether He Would Ever Reprise His 'Vampire Diaries' Role'Eight years is a long time...'
Les mer »
18 Actors Who Turned Down Huge TV And Movie Roles, And Whether They Regret It'I'm not proud of it.'
Les mer »